🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Super excited that our ARC LIEF application for a cryo-FIB got funded! This was an excellent team effort led by the fabulous Eric Hanssen. rms.arc.gov.au/RMS/Report/Dow…

Out now 📢: PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum. By Stephen Scally, Alan Cowman & colleagues. Stephen Scally WEHI (Walter and Eliza Hall Institute) #malaria nature.com/articles/s4156…

What an incredible group of visible role models! Congratulations to the new cohort of the #SuperstarsofSTEM. A great program to increase visibility and impact of STEM and showing the next generation diversity of careers that are possible. Looking forward to meeting you all

Please RT this exciting opportunity for Scientist Entrepreneur to join our Business Development Office WEHI (Walter and Eliza Hall Institute). A position between the BDO team and scientists to help expedite development of novel cell therapy projects towards the clinic. wehi.wd3.myworkdayjobs.com/en-US/WEHI/job…

WINNER of LSQ QIMR BERGHOFER WOMAN OF INFLUENCE AWARD Prof Kate Schroder at Institute for Molecular Bioscience developing drug targets for inflammasomes & startup Inflazome. The $620M sale to Roche is Australia’s largest academic deal. Thankyou to sponsor @QIMRBerghofer

AI leader Prof @DidarZowghi has been announced as an Advisor for next year's Women in AI Asia Pacific awards💡 Please join us in congratulating her! Prof Zowghi is a driving force behind our Diversity & Inclusion in AI research program & a renowned info tech educator.

BREAKING: Our Free Trade Agreement with India has passed through parliament. (📷 with Narendra Modi at the G20)

A world-first report, 'Artificial Intelligence for Science' has analysed the impact of AI on scientific discovery, finding scientists are adopting the technology at an unprecedented rate 🧠 📈 Read the report here: bit.ly/3EUPPYh #artificialintelligence #AIAustralia

"This project has involved more than 30 people at WEHI (Walter and Eliza Hall Institute) & more than 50 in the pharma company. I would also like to thank and acknowledge this large team of collaborators." Prof Alan Cowman AC upon winning the CSL Florey Medal for his contributions in malaria research.

So excited WEHI (Walter and Eliza Hall Institute) is part of this new company!! Innovative biotechnology founded on quality research.

Finally TYK2 from the good old JAK family worth upto $6B! Takeda acquires Nimbus Therapeutics allosteric TYK2 inhibitor, potential to be a best-in-class medicine in multiple disease areas. Congratulations team at Nimbus. cc @ausmedchemist Isa Lucet Jeff Babon James Murphy

Why do some recomb proteins express better than others? After expressing >2000 proteins from the human secretome in CHO cells, we identified the protein features and host cell pathways linked to poor expression. See our latest preprint biorxiv.org/content/10.110…

New plengegen.com blog series: discovery moments. The first adventure story is about a favorite target, TYK2. plengegen.com/blog/tyk2/

Excited to share our recent paper detailing the development of the affinity-directed phosphatase (#AdPhosphatase) system for targeted protein #dephosphorylation 🎯 . cell.com/cell-chemical-… . Gopal Sapkota Sapkota Lab Sapkota Lab UoD Life Sciences

Thrilled about our latest Pseudokinase research online today in Nature Communications, providing in depth insights into PEAK pseudokinases interaction with key cancer signalling regulators 14-3-3, Grb2 and CrkII. rdcu.be/deQ7o

Researchers uncover crucial interactions between PEAK pseudokinases & key signalling proteins controlling cell migration – a crucial step towards identifying new cancer therapeutics. Published in Nature Communications. WEHI (Walter and Eliza Hall Institute) Isa Lucet Michael Roy Dr Onisha Patel. nature.com/articles/s4146…

From LAB to PATIENTS. Great to be part of a team with Andrew Wilks @ausmedchemist Isa Lucet +others on discovering #momelotinib at a little known Melbourne #drugdiscovery startup Cytopia back in early 2000. Now approved by U.S. FDA for #myelofibrosis patients with anaemia 🎉 🎉🎉

GSK U.S. FDA 20 years ago, I kicked off a Structural Biology Program in Prof. Jamie Rossjohn lab on JAK kinases with Cytopia, Andrew Wilks, lead chemist Chris @ausmedchemist & a stellar team Dr Onisha Patel & others. Witnessing JAK inhibitor #momelotinib gaining approval fills me with immense pride.

A shining example of innovation, showcasing the power of integrating structural biology in early drug discovery and academia/industry partnership. Kudos to the incredible teams at Monash & Cytopia. Special shoutout to the many women involved #WomenInScience

A fantastic achievement for a home-grown Australian discovery. Congrats to WEHI #structuralbiologists, Isa Lucet Dr Onisha Patel for their contribution to structure-based #drugdiscovery of #momelotinib during their time at Monash University in partnership with Cytopia. #WomenInScience